Pediatrics, Pediatric Endocrinology · Indianapolis, IN
NPI
1326178971
Since 2007
Specialty
Pediatrics, Pediatric Endocrinology
Code 2080P0205X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
550 University Blvd, Ste 2180
Indianapolis, IN, 46202
Phone (317) 944-7718
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,202
142 services
Medicare patients, 2024
59
Average age 66
Drug cost, 2024
$1.1M
325 prescriptions
Company payments, 2025
$13K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Erik A Imel was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 42 times for 36 patients. In total Erik A Imel billed 142 services in 8 codes, and Medicare paid $7,202.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-10.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 42 | 36 | $11.34 | $476 |
| 99214 Office E&M - Established | Facility | 28 | 25 | $61.54 | $1,723 |
| 99215 Office E&M - Established | Facility | 16 | 15 | $92.56 | $1,481 |
By year: 2022 $9,181 for 144 services; 2023 $9,227 for 137 services; 2024 $7,202 for 142 services.
Medicare prescription drug claims, 2024
In 2024, the drug Erik A Imel prescribed most often to Medicare patients was Levothyroxine Sodium, with 87 prescriptions and refills. In total Erik A Imel wrote 325 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 87 | 158 | 17 | $960 |
| Crysvita Burosumab-Twza | 38 | 38 | Under 11 | $1.0M |
| Hydrocortisone Generic | 31 | 44 | Under 11 | $2,478 |
| Alendronate Sodium Generic | 21 | 57 | Under 11 | $115 |
| Calcitriol Generic | 14 | 33 | Under 11 | $685 |
| Fludrocortisone Acetate Generic | 13 | 13 | Under 11 | $172 |
| Forteo Teriparatide | 12 | 12 | Under 11 | $60K |
| Solu-Cortef Hydrocortisone Sodium Succ/Pf | 11 | 11 | Under 11 | $451 |
Brand drugs: - claims; generic drugs: 207 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Erik A Imel $13K ($9,531 in general payments such as food, travel and fees and $3,376 for research) from 7 companies. The largest payer was Kyowa Kirin, Inc. with $8,454.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.